These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21449879)

  • 1. Hydroxychloroquine retinopathy: screening needed to prevent blindness.
    Hodson TJ
    Med J Aust; 2011 Jan; 194(1):55. PubMed ID: 21449879
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxychloroquine retinopathy: screening needed to prevent blindness.
    Ojaimi E; Guymer RH; Wong TY; Harper CA
    Med J Aust; 2010 Jun; 192(11):668-9. PubMed ID: 20528723
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.
    Marmor MF; Carr RE; Easterbrook M; Farjo AA; Mieler WF;
    Ophthalmology; 2002 Jul; 109(7):1377-82. PubMed ID: 12093666
    [No Abstract]   [Full Text] [Related]  

  • 4. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
    Aduriz-Lorenzo PM; Aduriz-Llaneza P; Araiz-Iribarren J; Khamashta MA
    Lupus; 2020 Jun; 29(7):671-675. PubMed ID: 32316844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to set up a Hydroxychloroquine Retinopathy Screening Service.
    Zaidi FH; Rennie CA; Drinkwater AK; Sahu D; Akyol E; Lotery AJ
    Eye (Lond); 2019 Nov; 33(11):1679-1682. PubMed ID: 31028287
    [No Abstract]   [Full Text] [Related]  

  • 6. The gathering storm: hydroxychloroquine retinopathy screening in the U.K.
    Tucker WR; Galloway J; Walsh S
    Br J Dermatol; 2017 Jun; 176(6):1420-1421. PubMed ID: 28581233
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical characteristics of hydroxychloroquine retinopathy.
    Payne JF; Hubbard GB; Aaberg TM; Yan J
    Br J Ophthalmol; 2011 Feb; 95(2):245-50. PubMed ID: 20693556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy.
    Marmor MF
    Arthritis Rheum; 2003 Jun; 48(6):1764. PubMed ID: 12794848
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for hydroxychloroquine retinopathy. Screening should be selective.
    May K; Metcalf T; Gough A
    BMJ; 1998 Nov; 317(7169):1388-9. PubMed ID: 9812951
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for hydroxychloroquine toxicity.
    Pulido JS; Barkmeier AJ; Leavitt JA; Lewis RA
    Ophthalmology; 2012 Jan; 119(1):207; author reply 207-8. PubMed ID: 22214958
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular toxicity of hydroxychloroquine.
    Tehrani R; Ostrowski RA; Hariman R; Jay WM
    Semin Ophthalmol; 2008; 23(3):201-9. PubMed ID: 18432546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
    Marmor MF
    Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxychloroquine screening.
    Lee AG
    Br J Ophthalmol; 2005 May; 89(5):521-2. PubMed ID: 15834072
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxychloroquine retinopathy: is screening necessary?
    Blyth C; Lane C
    BMJ; 1998 Mar; 316(7133):716-7. PubMed ID: 9529393
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.
    Law LS; Lo EA; Yeoh SF
    Am J Ophthalmol; 2021 Feb; 222():399-400. PubMed ID: 33223050
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for hydroxychloroquine toxicity in children.
    Modjtahedi BS; Movassagh N; Gandhi N; Morse LS; Maibach HI
    Cutan Ocul Toxicol; 2013 Oct; 32(4):344. PubMed ID: 23607658
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.
    Browning DJ; Yokogawa N; Greenberg PB; Perlman E
    Am J Ophthalmol; 2021 Feb; 222():400-401. PubMed ID: 33228963
    [No Abstract]   [Full Text] [Related]  

  • 18. Spectral-domain optical coherence tomography in hydroxychloroquine retinopathy.
    Johnston JL; Darvill P; Thomson GT
    Ophthalmology; 2015 Mar; 122(3):651-2. PubMed ID: 25530224
    [No Abstract]   [Full Text] [Related]  

  • 19. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG.
    Marmor MF
    Am J Ophthalmol; 2005 Nov; 140(5):894-5. PubMed ID: 16310466
    [No Abstract]   [Full Text] [Related]  

  • 20. A subtle case of hydroxychloroquine retinopathy: spectral domain optical coherence tomography findings.
    Barnes AC; Bhavsar KV; Weber ML; Witkin AJ
    Eye (Lond); 2014 Dec; 28(12):1521-2. PubMed ID: 25214000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.